查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832308

生物可吸收聚合物市场（按产品、形式、製造流程、材料类型、应用和最终用户划分）—2025-2032 年全球预测

Bioresorbable Polymers Market by Product, Form, Manufacturing Process, Material Type, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，生物可吸收聚合物市场将成长至 22.6558 亿美元，复合年增长率为 10.78%。

主要市场统计数据
基准年2024年 9.9848亿美元
预计2025年 1,101,030,000美元
预测年份：2032年 2,265,580,000美元
复合年增长率（%） 10.78%

生物可吸收聚合物是一类旨在在生物环境中安全降解的材料。聚合物化学和加工技术的最新进展使得精确调节降解速率、增强生物相容性以及实现兼具治疗和结构功能的多功能结构成为可能。因此，这些材料正成为医疗设备、药物传输和组织工程的关键推动力，而这些领域此前主要由永久性植入或不可降解系统主导。

同时，转化科学正与先进製造技术融合，以生产纤维、薄膜、微粒和奈米级结构，拓展临床医生和产品开发者的设计视野。这些发展得到了越来越多的临床前和临床证据的支持，这些证据定义了安全性和性能基准。因此，相关人员现在正面临一个关键时刻：随着生物可吸收解决方案的技术相关性日益成熟，关键挑战正转向与法律规范的整合、供应链的稳健性和临床可接受性。

这项技术的采用为深入探讨材料类别、加工方法、特定应用要求以及策略行动奠定了基础，旨在加速应用并降低营运风险。后续章节将全面说明技术变革、政策影响、细分市场资讯、地理变化、竞争定位，并为参与生物可吸收聚合物生态系统的组织提供实用建议。

聚合物化学、精密製造和临床需求的进步如何融合，重新定义可吸收医疗材料的未来发展方向

材料创新、精密製造和跨领域合作正在改变生物可吸收聚合物的模式。在材料层面，新兴材料正在提供可调控的降解性和功能基团相容性，超越传统的聚乳酸体系，包括共聚物和专用骨架。这种不断扩展的材料套件使开发人员能够针对特定临床情况（例如承重整形外科应用和精细的血管介入）优化机械性能和降解特性。

在製造业，积层製造和先进的成型技术正从原型製作转向标准化生产，从而实现传统方法无法实现的工程化支架和设备功能。这些工艺创新与材料科学相结合，正在降低变异性并提高可重复性。此外，为了满足业界对一致性的期望，人们越来越重视可扩展的灭菌方法和「品质源自于设计」的典范。

临床医生越来越重视能够减少二次手术和长期异物併发症的器械，这支持了人们对支架、固定装置以及用于局部给药的可吸收替代方案的兴趣。此外，跨部门合作连接学术团体、临床研究人员和行业开发者，透过整合专业知识、共用生物库资源和转化试验网络，加速了转化途径。总而言之，这些转变正在创造一个更模组化、循证且能够可预测地将复杂的生物可吸收解决方案推向市场的生态系统。

评估2025年美国关税变化对营运和供应链的调整及策略影响

政策和贸易环境对生物可吸收聚合物价值链产生了实际的影响，美国近期于2025年实施的关税改变了中间原料、特殊聚合物和精密机械的进口动态。这些政策调整迫使製造商重新评估筹资策略，其直接影响集中在依赖国际原材料流和进口挤出、射出成型和微加工设备资本财的供应商身上。

为了应对这项挑战，一些製造商已实现供应基地多元化，或选择在更靠近终端市场的地方进行合约製造，以缓解边境相关不利因素。另一些製造商则加快了替代聚合物等级的认证或本地化供应商，以减轻关税引发的成本波动的影响。累积的营运效应包括加强库存管理、重新谈判供应商合约以及加强对物流韧性的投资。虽然大型跨国生产商透过整合供应网络吸收了部分影响，但中小型生产商感受到了定价和前置作业时间的压力，这影响了计划进度和伙伴关係谈判。

重要的是，这些关税主导的调整也活性化了围绕关键中间体垂直整合和加强国内生产力计画的讨论。有利于本地采购材料的监管调整和采购政策可以进一步影响采用轨迹。决策者必须评估供应商风险，保持灵活的筹资策略，并预测考虑潜在贸易政策波动的采购时间表。

深度细分观点展示产品形式、製造路线、材料化学和应用的需求如何影响策略优先顺序

細項分析透过考虑产品、形态、製造流程、材料类型、应用和最终用户等维度，揭示出细微的商业机会和绩效驱动因素。沿着产品轴线评估时，此细分市场包括纤维、薄膜、微粒和奈米材料，每种材料都具有独特的功能优势：纤维提供定向强度和孔隙度控制，薄膜具有阻隔和舒适功能，微粒有助于实现可注射或可植入的药物储存，奈米材料则支持细胞层面的靶向相互作用。同时，形态因素（液体、粉末或固体）决定了处理方式、灭菌选项和合适的下游製造方法，从而影响解决方案可以进入哪些临床工作流程。

製造流程包括吹塑成型、挤出和射出成型，每种製程都需要在产量、形状复杂性和材料相容性之间进行权衡。设计人员选择合适的製程来满足器械的形态、规模和精度需求，同时要认识到製程引起的应力和热历史会对劣化行为产生显着影响。聚酸酐、聚己内酯、Polyglycolic、聚羟基烷酯等化学材料可提供各种降解动力学和机械性能，以满足特定的临床需求。

药物输送系统，例如控制释放製剂和特异性载体，利用可吸收基质来局部治疗并最大限度地减少全身暴露。医疗植入，尤其是心血管支架和整形外科植入，利用临时机械支撑，然后安全吸收，消除异物的长期存在。组织工程专注于支架设计和干细胞支架来引导再生，而创伤治疗装置，例如黏合剂溶液和敷料，则利用临时材料来促进修復。最后，最终用户类别——生物技术公司、医院诊所、製药公司和研究机构——正在透过不同的采购週期、监管预期和临床部署路径来塑造应用程式。这些细分有助于确定研发投资、製造能力和商业化策略的优先顺序。

美洲、欧洲、中东和非洲以及亚太地区的区域动态正在影响监管途径、製造地决策和临床应用

地域因素在美洲、欧洲、中东和非洲以及亚太地区的技术采用、监管趋势和供应链发展中发挥关键作用。在美洲，临床界和报销结构青睐能够降低再治疗和长期治疗成本的创新，从而支持了人们对可吸收植入和局部给药解决方案的兴趣。法规环境强调安全性和临床证据，鼓励积极参与临床试验和机构合作，以加速转化。

在欧洲、中东和非洲地区，一些国家的监管协调倡议和集中审查流程提供了更清晰的途径，而另一些国家则要求提供全面的技术文件并承诺进行上市后监督。临床偏好模式和采购机制也各不相同，主要企业根据每个地区制定打入市场策略。同样，欧洲、中东和非洲地区的采购通常强调生命週期成本和临床结果，从而强化了能够显着减少长期併发症的设备的价值提案。

亚太地区呈现出一个多元化但快速成熟的生态系统，拥有强大的製造能力和日益增长的临床试验活动。该地区的多个经济体正在投资国内聚合物和医疗设备製造能力，为全球企业创造了竞争优势和合作机会。亚太地区供应链的接近性缩短了区域製造商的前置作业时间，许多市场的监管现代化正在为新型可吸收解决方案创造清晰的临床路径。总而言之，这些区域动态推动着关于製造地、临床伙伴关係和监管参与的决策，以优化产品应用和患者疗效。

竞争格局概览：现有企业、利基创新者和学术衍生企业如何制定其商业化和伙伴关係策略

生物可吸收聚合物的竞争格局呈现出以下特点：特种聚合物供应商、整合材料专业知识的设备製造商，以及主导于新型化学和结构的研究型新参与企业。现有企业利用其规模、检验的製造平台和监管经验，致力于心血管和整形外科植入等高度合规的应用。这些现有企业通常强调品管系统、可追溯性和丰富的临床资料集，以支持市场认可。

同时，规模较小的利基公司正在配方科学、先进製程和特定应用的调整方面做出创新贡献。他们的敏捷性使他们能够快速迭代材料混合和表面改性，以满足尚未满足的临床需求。专业材料开发商和医疗设备製造商之间的合作日益普遍，促成了共同开发契约、许可协议和战略伙伴关係关係，将材料特性与医疗设备功能相匹配。

此外，学术衍生公司和研究机构仍是颠覆性概念的重要来源，尤其是在刺激反应降解、多层次支架结构和生技药品整合等领域。对于在这种竞争格局中生存的公司而言，关键的差异化优势通常在于已证实的临床效用、规模化生产能力以及清晰的监管环境。策略联盟、有针对性的智慧财产权保护以及对生产合格的投资是将技术优势转化为商业性吸引力的审慎机制。

为高阶主管提供可行的策略重点，将聚合物科学的进步转化为可扩展、临床检验和商业性可行的解决方案

为了加速价值实现，产业领导者应优先考虑一系列切实可行的行动，将科学前景与营运可行性结合。首先，投资于可靠的材料表征和体内外相关性研究，以将降解特征与性能终点联繫起来。这些数据将减少监管的不确定性，并增强临床医生的信心。其次，推行模组化生产策略，使其能够从中试规模扩展到商业化规模，同时保持对材料和製程的控制。

第三，我们透过多元化采购、与策略供应商合作以及关键中间体的本地生产来增强供应链的韧性，以缓解贸易政策和物流中断的影响。与医疗保健系统合作建立註册网路可以提供纵向数据，从而增强报销能力。第五，我们培养跨职能团队，在开发早期整合监管、临床、生产和商业方面的专业知识，以避免后期返工，并使产品特性与应用促进要素保持一致。

最后，考虑透过许可、合资企业、共同开发契约等方式利用互补能力的智慧财产权策略和合作模式。透过同时实施这些建议，组织可以加快临床时间，降低部署风险，并加强先进生物可吸收解决方案的商业性案例。

结合专家访谈、文献综合和比较技术评估的综合方法确保了证据驱动、可操作的见解

本研究综合报告也补充了对材料科学家、研发专业人员、临床研究人员和供应链专家的初步访谈，以及对同行评审文献和监管文件的系统性回顾。初步资讯旨在捕捉技术准备、生产限制、临床偏好和采购考量。访谈主题透过跨资讯来源三角测量，以检验研究结果并识别趋同趋势。

分析方法包括：根据特定应用的性能标准对材料类别进行比较评估，根据常见生产路线进行製程适用性评估，以及供应链中断情境分析。强调交叉验证，将开发商的技术声明与独立实验室报告和临床试验註册（如有）进行检验核对。监管考虑源自官方机构指南、产品认证和上市后监管摘要，以确保符合当前预期。

我们的研究方法优先考虑假设和资料来源的透明度。在切实可行的情况下，我们识别了研究的局限性和知识缺口，指南未来的研究，并为在生物可吸收聚合物领域考虑投资、合作和临床项目的利益相关人员提供循证决策。

总结性结论强调了综合实施在将生物可吸收聚合物创新转化为持续临床影响方面的关键作用

生物可吸收聚合物处于材料科学、临床需求和製造能力的策略性交会点。化学、加工技术和协作转化生态系统的进步降低了技术壁垒，并扩展了可行的临床应用组合。然而，要充分发挥这些材料的潜力，需要在证据生成、供应链设计和监管参与方面采取审慎的行动，以确保其在规模化生产中一致的性能。

相关人员若能将严格的材料特性、可扩展的製造方法和有针对性的临床证据项目结合，最有可能获得临床和经济价值。政策动态、监管和采购实践的地区差异进一步凸显了製定本地化策略和灵活供应网络的必要性。最终，将科学创新与营运原则和策略伙伴关係关係相结合的组织将创造出最持久的采用途径，提供以患者为中心的解决方案，从而减轻干预负担并改善长期疗效。

这个结论强调了一个现实的观点：虽然技术准备已经很先进，但策略执行仍然是原型承诺和广泛临床影响之间的区别。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 可调降解速率的多层生物可吸收血管支架的研究进展
  • 将生物可吸收聚合物整合到药物释放型支架中以实现控制释放曲线
  • 开发高强度生物可吸收整形外科固定装置，减少二次手术
  • 越来越多地采用基于生物可吸收聚合物的手术网片，以尽量减少异物反应
  • 针对患者客製化的生物可吸收聚合物植入的新兴积层製造
  • 监管协调对生物可吸收聚合物医疗设备核准时间的影响
  • 丙交酯-乙交酯共聚物配方的创新提高了机械完整性
  • 具有持续抗菌活性的生物可吸收聚合物伤口敷料的开发

第六章 2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章生物可吸收聚合物市场（按产品）

  • 纤维
  • 电影
  • 细颗粒
  • 奈米材料

9. 生物可吸收聚合物市场（依形态）

  • 液体
  • 粉末
  • 固体的

第 10 章。生物可吸收聚合物市场（依製造製程）

  • 吹塑成型
  • 挤压
  • 射出成型

第 11 章生物可吸收聚合物市场（依材料类型）

  • 聚酸酐
  • 聚己内酯（PCL）
  • Polyglycolic（PGA）
  • 聚羟基烷酯（PHA）
  • 聚乳酸（PLA）

第12章生物可吸收聚合物市场（依应用）

  • 药物输送系统
    • 控制释放製剂
    • 目标特异性载体
  • 医疗植入
    • 心血管支架
    • 整形外科植入
  • 组织工程
    • 骨架设计
    • 干细胞支架
  • 创伤治疗装置
    • 黏合剂解决方案
    • 包扎材料

第 13 章生物可吸收聚合物市场（依最终使用者）

  • 生技公司
  • 医院和诊所
  • 製药公司
  • 研究所

第14章生物可吸收聚合物市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章。生物可吸收聚合物市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章生物可吸收聚合物市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Corbion NV
    • REVA Medical, LLC
    • Evonik Industries AG
    • Ashland Inc.
    • Poly-Med Incorporated
    • Zeus Industrial Products, Inc.
    • Foster Corporation
    • SEQENS SAS
    • Merck KGaA
    • Advanced Polymer Materials Inc.
Product Code: MRR-437D45957EE1

The Bioresorbable Polymers Market is projected to grow by USD 2,265.58 million at a CAGR of 10.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 998.48 million
Estimated Year [2025] USD 1,101.03 million
Forecast Year [2032] USD 2,265.58 million
CAGR (%) 10.78%

Bioresorbable polymers represent a class of materials engineered to degrade safely within biological environments while delivering functional performance during their intended service life. Recent advances in polymer chemistry and processing techniques have enabled precisely tuned degradation kinetics, enhanced biocompatibility, and multifunctional constructs that serve therapeutic and structural roles. As a result, these materials are emerging as critical enablers across medical devices, drug delivery, and tissue engineering, where permanent implants or nondegradable systems previously dominated.

Concurrently, translational science is converging with advanced manufacturing to produce architectures at the fiber, film, micro-particle, and nanoscale levels, expanding the design space for clinicians and product developers. These developments are supported by a growing corpus of preclinical and clinical evidence that clarifies safety profiles and performance benchmarks. Therefore, stakeholders now face a pivotal moment: the technical plausibility of bioresorbable solutions has matured, and the primary challenges shift toward integration with regulatory frameworks, supply chain robustness, and clinical acceptance.

This introduction sets the stage for a nuanced exploration of material classes, processing modalities, application-specific demands, and strategic actions that can accelerate adoption while mitigating operational risk. The succeeding sections synthesize technological shifts, policy impacts, segmentation intelligence, geographic variations, competitive positioning, and pragmatic recommendations for organizations engaged in the bioresorbable polymer ecosystem.

How advances in polymer chemistry, precision manufacturing, and clinical demand are converging to redefine the future pathways for resorbable medical materials

The landscape for bioresorbable polymers is undergoing transformative shifts driven by material innovation, precision manufacturing, and cross-disciplinary collaboration. At the material level, the palette of available chemistries has broadened beyond traditional polylactide systems to include copolymers and specialty backbones that afford tailored degradation and functional group compatibility. This expanded material toolkit enables developers to optimize mechanical properties and degradation profiles for specific clinical contexts, such as load-bearing orthopedic applications or delicate vascular interventions.

In manufacturing, additive and advanced molding techniques are moving from prototyping to regulated production, enabling architected scaffolds and device features previously unattainable with conventional methods. Such process innovation interacts with material science to reduce variability and enhance reproducibility, which in turn eases regulatory review pathways. Additionally, there is a growing emphasis on scalable sterilization approaches and quality-by-design paradigms that align with industry expectations for consistency.

Healthcare delivery trends are also reshaping demand: clinicians increasingly prioritize devices that reduce secondary procedures and long-term foreign body complications, which supports interest in resorbable alternatives for stents, fixation devices, and localized drug depots. Moreover, cross-sector collaborations-linking academic groups, clinical investigators, and industry developers-accelerate translational pathways by combining domain expertise, shared biobanking resources, and translational trial networks. Collectively, these shifts point toward an ecosystem that is more modular, evidence-driven, and capable of bringing complex bioresorbable solutions to market with improved predictability.

Assessment of the operational and supply chain adjustments prompted by United States tariff changes in 2025 and their strategic implications

Policy and trade environments have a tangible influence on the bioresorbable polymers value chain, and recent tariff measures introduced in the United States in 2025 altered import dynamics for intermediate feedstocks, specialty polymers, and precision equipment. These policy adjustments have prompted manufacturers to reassess sourcing strategies, with near-term effects concentrated on suppliers dependent on international raw-material flows or on capital goods imported for extrusion, injection molding, and microfabrication equipment.

In response, some manufacturers have diversified supply bases or engaged in contract manufacturing closer to end markets to mitigate border-related headwinds. Others have accelerated qualification of alternative polymer grades and localized suppliers to reduce exposure to tariff-induced cost volatility. The cumulative operational effect includes tighter inventory management, renegotiated supplier contracts, and increased investment in logistic resiliency. While larger multinational producers have absorbed a portion of the impact through integrated supply networks, smaller and mid-sized producers felt acute pricing and lead-time pressures that influenced project timelines and partnership negotiations.

Importantly, these tariff-driven adjustments also stimulated conversations around vertical integration for critical intermediates and enhanced domestic capacity planning. Regulatory alignment and procurement policies that favor locally supplied materials can further shape adoption pathways. For decision-makers, the key takeaway lies in evaluating supplier risk, maintaining flexible sourcing strategies, and anticipating procurement timelines that account for potential trade-policy volatility.

Deep segmentation perspective showing how product forms, manufacturing routes, material chemistries, and application demands inform strategic prioritization

Segmentation analysis reveals nuanced opportunities and performance drivers when examined across product, form, manufacturing process, material type, application, and end-user dimensions. When evaluated on the product axis, the field encompasses fibers, films, micro-particles, and nanomaterials, each offering distinct functional advantages: fibers provide directional strength and porosity control, films enable barrier and conformability functions, micro-particles facilitate injectable or implantable drug depots, and nanomaterials support targeted interactions at the cellular level. In parallel, the form factor-liquid, powder, or solid-dictates handling, sterilization choices, and suitable downstream fabrication approaches, influencing which clinical workflows a solution can enter.

Manufacturing processes span blow molding, extrusion, and injection molding, and each presents trade-offs among throughput, geometric complexity, and material compatibility. Designers select processes to match device geometry, scale, and precision needs, recognizing that process-induced stresses and thermal histories can materially affect degradation behavior. Material type remains a primary determinant of performance, with chemistries such as polyanhydrides, polycaprolactone, polyglycolic acid, polyhydroxyalkanoate, and polylactic acid offering diverse degradation kinetics and mechanical profiles that align with specific clinical demands.

Application-driven segmentation illustrates where value accrues: drug delivery systems, including controlled-release formulations and target-specific vehicles, exploit resorbable matrices to localize therapy and minimize systemic exposure. Medical implants, notably cardiovascular stents and orthopedic implants, leverage temporary mechanical support followed by safe resorption to eliminate long-term foreign body presence. Tissue engineering efforts focus on scaffold designs and stem cell scaffolding to guide regeneration, while wound healing devices such as adhesive solutions and bandaging materials use transient material presence to promote repair. Finally, end-user categories-biotechnology companies, hospitals and clinics, pharmaceutical companies, and research institutes-shape adoption through differing procurement cycles, regulatory expectations, and clinical deployment pathways. Together, these segmentation lenses inform prioritization of R&D investment, manufacturing capacity, and commercialization strategies.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping regulatory pathways, manufacturing footprint decisions, and clinical adoption

Geographic considerations play a significant role in technology adoption, regulatory trajectories, and supply chain architecture across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinical communities and reimbursement structures favor innovations that reduce repeat interventions and long-term care costs, which supports interest in resorbable implants and localized drug delivery solutions. The regulatory environment emphasizes safety and clinical evidence, prompting robust clinical trial engagement and institutional partnerships that can accelerate translation.

Across Europe, the Middle East & Africa, regulatory harmonization initiatives and centralized review processes in some jurisdictions facilitate pathway clarity but also require comprehensive technical documentation and post-market surveillance commitments. Clinical preference patterns and procurement mechanisms vary, leading companies to adopt regionally tailored market-entry strategies. Similarly, EMEA procurement often stresses lifecycle cost and clinical outcomes, reinforcing the value proposition of devices that demonstrably reduce long-term complications.

The Asia-Pacific region exhibits a heterogeneous but rapidly maturing ecosystem, with significant manufacturing capacity and growing clinical trial activity. Several economies in the region are investing in domestic polymer and medical-device capabilities, which creates both competitive advantages and collaborative opportunities for global players. Supply chain proximity in Asia-Pacific can reduce lead times for regional manufacturers, while regulatory modernization in many markets is creating clearer clinical pathways for novel resorbable solutions. Taken together, these regional dynamics inform decisions about manufacturing footprints, clinical partnerships, and regulatory engagements to optimize adoption and patient outcomes.

Competitive landscape insights highlighting how incumbents, niche innovators, and academic spinouts are shaping commercialization and partnership strategies

Competitive dynamics within the bioresorbable polymer landscape are characterized by a mix of specialty polymer suppliers, device manufacturers with integrated materials expertise, and research-driven entrants focused on novel chemistries or architected structures. Established firms leverage scale, validated manufacturing platforms, and regulatory experience to pursue high-compliance applications such as cardiovascular and orthopedic implants. These incumbents often emphasize quality management systems, traceability, and extensive clinical datasets to support market acceptance.

At the same time, smaller and niche players contribute innovation in formulation science, advanced processing, and application-specific adaptations. Their agility enables rapid iteration on material blends and surface modifications that can address unmet clinical needs. Collaboration between specialized material developers and device manufacturers is increasingly common, yielding co-development agreements, licensing arrangements, and strategic partnerships that align material properties with device function.

Furthermore, academic spin-outs and research institutes remain important sources of disruptive concepts, particularly in areas like stimulus-responsive degradation, hierarchical scaffold architectures, and integration of biologics. For organizations navigating this competitive landscape, differentiation often hinges on demonstrable clinical benefit, manufacturability at scale, and a clear regulatory strategy. Strategic alliances, targeted IP protection, and investments in manufacturing qualification are prudent mechanisms to convert technical advantage into commercial traction.

Actionable strategic priorities for executives to convert polymer science advancements into scalable, clinically validated, and commercially viable solutions

Industry leaders should prioritize a set of pragmatic actions that bridge scientific promise with operational execution to accelerate value realization. First, invest in robust materials characterization and in vitro-to-in vivo correlation studies that link degradation profiles to performance endpoints. Such data will reduce regulatory uncertainty and support clinician confidence. Second, pursue modular manufacturing strategies that allow scaling from pilot to commercial volumes while preserving material and process control; adopting quality-by-design principles can reduce variability and speed device qualification.

Third, develop supply chain resilience through diversified sourcing, strategic supplier partnerships, and where appropriate, localized production for critical intermediates to mitigate trade-policy or logistic disruptions. Fourth, structure clinical evidence generation to demonstrate meaningful patient outcomes and economic value; partnering with healthcare systems and forming registry networks can produce longitudinal data that reinforce reimbursement positions. Fifth, cultivate cross-functional teams that integrate regulatory, clinical, manufacturing, and commercial expertise early in development to avoid late-stage rework and to align product features with adoption drivers.

Finally, consider IP strategies and collaborative models that unlock complementary capabilities, whether through licensing, joint ventures, or co-development agreements. By executing these recommendations in parallel, organizations can reduce time-to-clinic, lower deployment risk, and strengthen the commercial case for advanced bioresorbable solutions.

Comprehensive methodology combining expert interviews, literature synthesis, and comparative technical evaluation to ensure evidence-based, actionable insights

This research synthesis integrates primary interviews with materials scientists, device developers, clinical investigators, and supply chain specialists, complemented by a systematic review of peer-reviewed literature and regulatory documentation. Primary inputs were structured to capture technology readiness, manufacturing constraints, clinical preferences, and procurement considerations. Interview themes were triangulated across sources to validate findings and identify convergent trends.

Analytical methods included comparative evaluation of material classes against application-specific performance criteria, process compatibility assessments for common manufacturing routes, and scenario analysis of supply chain disruptions. Emphasis was placed on cross-validation: technical claims from developers were checked against independent bench reports and clinical trial registries where available. Regulatory considerations were derived from public agency guidance, product clearances, and post-market surveillance summaries to ensure alignment with current expectations.

The research approach also prioritized transparency in assumptions and data provenance. Wherever practical, limitations and knowledge gaps are identified to guide future investigation and to support evidence-based decision-making by stakeholders considering investments, partnerships, or clinical programs in the bioresorbable polymers domain.

Concluding synthesis emphasizing the pivotal role of integrated execution in translating bioresorbable polymer innovations into durable clinical impact

Bioresorbable polymers occupy a strategic intersection of materials science, clinical need, and manufacturing capability. Advances in chemistries, processing technologies, and collaborative translational ecosystems have reduced technical barriers and expanded the portfolio of viable clinical applications. However, realizing the full potential of these materials requires deliberate action across evidence generation, supply chain design, and regulatory engagement to ensure consistent performance at scale.

Stakeholders that integrate rigorous materials characterization, scalable manufacturing practices, and targeted clinical evidence programs will be best positioned to capture clinical and economic value. Policy dynamics and regional differences in regulatory and procurement practices further emphasize the need for localized strategies and flexible supply networks. Ultimately, organizations that align scientific innovation with operational discipline and strategic partnerships will create the most durable pathways to adoption, delivering patient-centric solutions that reduce intervention burden and improve long-term outcomes.

This conclusion underscores a pragmatic view: technical readiness has advanced substantially, but strategic execution remains the differentiator between prototype promise and widespread clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advances in multi-layer bioresorbable vascular scaffolds with tunable degradation rates
  • 5.2. Integration of bioresorbable polymers in drug-eluting stents for controlled release profiles
  • 5.3. Development of high-strength bioresorbable orthopedic fixation devices reducing secondary surgeries
  • 5.4. Rising adoption of bioresorbable polymer-based surgical meshes to minimize foreign body reactions
  • 5.5. Emergence of additive manufacturing techniques for patient-specific bioresorbable polymer implants
  • 5.6. Regulatory harmonization impact on approval timelines for bioresorbable polymer medical devices
  • 5.7. Innovations in lactide-glycolide copolymer formulations improving mechanical integrity over time
  • 5.8. Development of bioresorbable polymer-based wound dressings with sustained antimicrobial activity

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioresorbable Polymers Market, by Product

  • 8.1. Fibers
  • 8.2. Films
  • 8.3. Micro-Particles
  • 8.4. Nanomaterials

9. Bioresorbable Polymers Market, by Form

  • 9.1. Liquid
  • 9.2. Powder
  • 9.3. Solid

10. Bioresorbable Polymers Market, by Manufacturing Process

  • 10.1. Blow Molding
  • 10.2. Extrusion
  • 10.3. Injection Molding

11. Bioresorbable Polymers Market, by Material Type

  • 11.1. Polyanhydrides
  • 11.2. Polycaprolactone (PCL)
  • 11.3. Polyglycolic Acid (PGA)
  • 11.4. Polyhydroxyalkanoate (PHA)
  • 11.5. Polylactic Acid (PLA)

12. Bioresorbable Polymers Market, by Application

  • 12.1. Drug Delivery Systems
    • 12.1.1. Controlled Release Formulations
    • 12.1.2. Target-Specific Vehicles
  • 12.2. Medical Implants
    • 12.2.1. Cardiovascular Stents
    • 12.2.2. Orthopedic Implants
  • 12.3. Tissue Engineering
    • 12.3.1. Scaffold Designs
    • 12.3.2. Stem Cell Scaffolding
  • 12.4. Wound Healing Devices
    • 12.4.1. Adhesive Solutions
    • 12.4.2. Bandaging Materials

13. Bioresorbable Polymers Market, by End-User

  • 13.1. Biotechnology Companies
  • 13.2. Hospitals and Clinics
  • 13.3. Pharmaceutical Companies
  • 13.4. Research Institutes

14. Bioresorbable Polymers Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioresorbable Polymers Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioresorbable Polymers Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Corbion NV
    • 17.3.2. REVA Medical, LLC
    • 17.3.3. Evonik Industries AG
    • 17.3.4. Ashland Inc.
    • 17.3.5. Poly-Med Incorporated
    • 17.3.6. Zeus Industrial Products, Inc.
    • 17.3.7. Foster Corporation
    • 17.3.8. SEQENS SAS
    • 17.3.9. Merck KGaA
    • 17.3.10. Advanced Polymer Materials Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BIORESORBABLE POLYMERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BIORESORBABLE POLYMERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIORESORBABLE POLYMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MICRO-PARTICLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY NANOMATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SOLID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYANHYDRIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYHYDROXYALKANOATE (PHA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CONTROLLED RELEASE FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TARGET-SPECIFIC VEHICLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY CARDIOVASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY SCAFFOLD DESIGNS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY STEM CELL SCAFFOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY ADHESIVE SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BANDAGING MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY MEDICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY WOUND HEALING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE POLYMERS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE BIORESORBABLE POLYMERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE BIORESORBABL